210 related articles for article (PubMed ID: 29643149)
1. Involvement of Prokineticin 2-expressing Neutrophil Infiltration in 5-Fluorouracil-induced Aggravation of Breast Cancer Metastasis to Lung.
Sasaki S; Baba T; Muranaka H; Tanabe Y; Takahashi C; Matsugo S; Mukaida N
Mol Cancer Ther; 2018 Jul; 17(7):1515-1525. PubMed ID: 29643149
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow-derived, alternatively activated macrophages enhance solid tumor growth and lung metastasis of mammary carcinoma cells in a Balb/C mouse orthotopic model.
Cho HJ; Jung JI; Lim DY; Kwon GT; Her S; Park JH; Park JH
Breast Cancer Res; 2012 May; 14(3):R81. PubMed ID: 22616919
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil recruitment is critical for 5-fluorouracil-induced diarrhea and the decrease in aquaporins in the colon.
Sakai H; Sagara A; Matsumoto K; Jo A; Hirosaki A; Takase K; Sugiyama R; Sato K; Ikegami D; Horie S; Matoba M; Narita M
Pharmacol Res; 2014 Sep; 87():71-9. PubMed ID: 24972040
[TBL] [Abstract][Full Text] [Related]
4. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
5. The Yin/Yan of CCL2: a minor role in neutrophil anti-tumor activity in vitro but a major role on the outgrowth of metastatic breast cancer lesions in the lung in vivo.
Lavender N; Yang J; Chen SC; Sai J; Johnson CA; Owens P; Ayers GD; Richmond A
BMC Cancer; 2017 Jan; 17(1):88. PubMed ID: 28143493
[TBL] [Abstract][Full Text] [Related]
6. Intraductal Adaptation of the 4T1 Mouse Model of Breast Cancer Reveals Effects of the Epithelial Microenvironment on Tumor Progression and Metastasis.
Atiya HI; Dvorkin-Gheva A; Hassell J; Patel S; Parker RL; Hartstone-Rose A; Hodge J; Fan D; Ramsdell AF
Anticancer Res; 2019 May; 39(5):2277-2287. PubMed ID: 31092419
[TBL] [Abstract][Full Text] [Related]
7. Curcumin Inhibits 5-Fluorouracil-induced Up-regulation of CXCL1 and CXCL2 of the Colon Associated with Attenuation of Diarrhoea Development.
Sakai H; Kai Y; Oguchi A; Kimura M; Tabata S; Yaegashi M; Saito T; Sato K; Sato F; Yumoto T; Narita M
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):540-547. PubMed ID: 27194111
[TBL] [Abstract][Full Text] [Related]
8. Monocyte chemoattractant protein-1/CCL2 produced by stromal cells promotes lung metastasis of 4T1 murine breast cancer cells.
Yoshimura T; Howard OM; Ito T; Kuwabara M; Matsukawa A; Chen K; Liu Y; Liu M; Oppenheim JJ; Wang JM
PLoS One; 2013; 8(3):e58791. PubMed ID: 23527025
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
Song H; Jung JI; Cho HJ; Her S; Kwon SH; Yu R; Kang YH; Lee KW; Park JH
J Nutr Biochem; 2015 Nov; 26(11):1368-78. PubMed ID: 26297476
[TBL] [Abstract][Full Text] [Related]
10. Crucial contribution of GPR56/ADGRG1, expressed by breast cancer cells, to bone metastasis formation.
Sasaki SI; Zhang D; Iwabuchi S; Tanabe Y; Hashimoto S; Yamauchi A; Hayashi K; Tsuchiya H; Hayakawa Y; Baba T; Mukaida N
Cancer Sci; 2021 Dec; 112(12):4883-4893. PubMed ID: 34632664
[TBL] [Abstract][Full Text] [Related]
11. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
12. Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis.
Sharma B; Nawandar DM; Nannuru KC; Varney ML; Singh RK
Mol Cancer Ther; 2013 May; 12(5):799-808. PubMed ID: 23468530
[TBL] [Abstract][Full Text] [Related]
13. Rebound increases in chemokines by CXCR2 antagonist in breast cancer can be prevented by PKCδ and PKCε activators.
Erin N; Tavşan E; Akdeniz Ö; Isca VMS; Rijo P
Cytokine; 2021 Jun; 142():155498. PubMed ID: 33773907
[TBL] [Abstract][Full Text] [Related]
14. Syndecan-1 induction in lung microenvironment supports the establishment of breast tumor metastases.
Chute C; Yang X; Meyer K; Yang N; O'Neil K; Kasza I; Eliceiri K; Alexander C; Friedl A
Breast Cancer Res; 2018 Jul; 20(1):66. PubMed ID: 29976229
[TBL] [Abstract][Full Text] [Related]
15. Neutrophils and Snail Orchestrate the Establishment of a Pro-tumor Microenvironment in Lung Cancer.
Faget J; Groeneveld S; Boivin G; Sankar M; Zangger N; Garcia M; Guex N; Zlobec I; Steiner L; Piersigilli A; Xenarios I; Meylan E
Cell Rep; 2017 Dec; 21(11):3190-3204. PubMed ID: 29241546
[TBL] [Abstract][Full Text] [Related]
16. Mast cell and macrophage chemokines CXCL1/CXCL2 control the early stage of neutrophil recruitment during tissue inflammation.
De Filippo K; Dudeck A; Hasenberg M; Nye E; van Rooijen N; Hartmann K; Gunzer M; Roers A; Hogg N
Blood; 2013 Jun; 121(24):4930-7. PubMed ID: 23645836
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.
Bandyopadhyay A; Wang L; Agyin J; Tang Y; Lin S; Yeh IT; De K; Sun LZ
PLoS One; 2010 Apr; 5(4):e10365. PubMed ID: 20442777
[TBL] [Abstract][Full Text] [Related]
18. Naringenin prevents TGF-β1 secretion from breast cancer and suppresses pulmonary metastasis by inhibiting PKC activation.
Zhang F; Dong W; Zeng W; Zhang L; Zhang C; Qiu Y; Wang L; Yin X; Zhang C; Liang W
Breast Cancer Res; 2016 Apr; 18(1):38. PubMed ID: 27036297
[TBL] [Abstract][Full Text] [Related]
19. The mouse mammary carcinoma 4T1: characterization of the cellular landscape of primary tumours and metastatic tumour foci.
DuPré SA; Redelman D; Hunter KW
Int J Exp Pathol; 2007 Oct; 88(5):351-60. PubMed ID: 17877537
[TBL] [Abstract][Full Text] [Related]
20. OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung.
Tawara K; Bolin C; Koncinsky J; Kadaba S; Covert H; Sutherland C; Bond L; Kronz J; Garbow JR; Jorcyk CL
Breast Cancer Res; 2018 Jun; 20(1):53. PubMed ID: 29898744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
